Essay Database
Management paper
Date Submitted: 12/25/2004 12:30:34
Category: / Business & Economy / Management
Length: 12 pages (3247 words)
Category: / Business & Economy / Management
Length: 12 pages (3247 words)
EntreMed Executive Summary 1.1 History and Background EntreMed, Inc., Maryland founded in 1991 and publicly-traded since 1996 (NASDAQ: ENMD) a clinical-stage biopharmaceutical company developing therapeutics that "act on multiple cellular pathways involved in processes such as abnormal blood vessel growth, inflammation, coagulation, and programmed cell death"(entremed.com) Through a combination of both foresight and fortuity, EntreMed, in 1993, initiated its collaboration with Dr. Judah Folkman, the father of angiogenesis, who, more than 30 years ago, discovered that tumors were …
Is this Essay helpful? Join now to read this particular paper
and access over 800,000 just like this GET BETTER GRADES
and access over 800,000 just like this GET BETTER GRADES
…Challener, C. (2003, February 24). Market reactions: Custom players offer their views from the trenches. Chemical Market Reporter. 8, FR3 Biotechnology - A Consistent Record of Growth, Biotechnology Industry Organization, www.bio.org Finding Funding - Opportunities and Caveats, About, Inc www.biotechabout.com Krause, C. (2003, March 17). Fewer financing opportunities in biotechnology sector has altered deal-making strategies. Chemical Market Reporter. 11, 12 Manufacturing, Human Genome Sciences, www.hgsi.com Scott, A. (2003, September 24). Biopharma manufacturing capacity comes into balance. Chemical Week. 33, 58
Need a custom written paper? Let our professional writers save your time.
Need an original paper?
